Assessment of polystyrene extract for estrogenic activity in the rat uterotrophic model and an in vitro recombinant receptor reporter gene assay

Drug and Chemical Toxicology

Volumn 21, Issue SUPPL. 1, 1998, Pages 101-121

  Fail, Patricia A ^a   Hines, John W ^a   Zacharewski, Tim ^b   Wu, Zhi Fen ^b   Borodinsky, Lester ^c  

^a RTI INTERNATIONAL   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Keller and Heckman   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN RECEPTOR; POLYSTYRENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; ESTROGEN ACTIVITY; EXTRACT; FEMALE; FOOD; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RAT; REPORTER GENE; SUBCUTANEOUS DRUG ADMINISTRATION; UTERUS GROWTH; UTERUS WEIGHT;

EID: 0032466667     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.3109/01480549809007405     Document Type: Article

References (32)

1. Colborn, T., vom Saal, F. S., and Soto, A. M., Developmental effects of endocrine-disrupting chemicals in wildlife and humans, Environ. Health Perspect., 101:378, 1993.
2. Davis, D. L., Bradlow, H. L., Wolff, M., Woodruff, T., Hoel, D. G., and Anton-Culver, H., Medical hypothesis: xenoestrogens as preventable causes of breast cancer, Environ. Health Perspect., 101:372, 1993.
3. Hileman, B., Environmental estrogens linked to reproductive abnormalities, cancer, Chem. Eng. News., Jan. 31:19, 1994.
4. Safe, S. H. Environmental and dietary estrogens and human health: is there a problem?, Environ. Health Perspect., 103:346, 1995.
5. Stone, R. Environmental estrogens stir debate, Science, 265:308, 1994.
6. Katzenellenbogen, J. A., The structural pervasiveness of estrogenic action, Environ. Health Perspect., 103(Suppl.7):99, 1995.
7. Gray, Jr., L. E., Kelce, W. R., Weise, T., Tyle, R., Gaido, K. and Cook, J., Endocrine screening methods workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity of chemicals that act via receptor or steroidogenic enzyme mechanisms, Toxicol. Indust. Health, 14(1/2):159, 1997.
8. Reel, J. R. Lamb, J. C., and Neal, B. H. Survey and assessment of mammalian estrogen biological assays for hazard characterization, Fund. Appl. Toxicol, 34:288, 1996.
9. Zacharewski, T., In vitro assays used to assess estrogenic substances, Environ. Sci. Tech., 31:613, 1997.
10. Bromwich, P., Cohen, J., Stewart, I., and Walker, A., Decline in sperm counts: an artefact of changed reference range of "normal", British Med. J. 309:19, 1994.
11. Food and Drug Administration, "Recommendations for Chemistry Data for Indirect Food Additive Petitions," September, 1995.
12. Astwood, E.B., Changes in the weight and water content of the uterus of the normal adult rat, Am. J Physiol., 126:162, 1939.
13. Zarrow, M.X., Yochim, J.M., and McCarthy, J.L., Experimental Endocrinology: A Sourcebook of Basic Techniques, The Estrogens, Chapter 2, Academic Press, 17-64, 1964.
14. Evans, R., The steroid and thyroid hormone receptor superfamily, Science, 240:889, 1988.
15. SAS Institute Inc., SAS/STAT® User's Guide, Volumes 1 and 2, Version 6, Fourth Edition, SAS Institute Inc., Cary, NC, 1686, 1989.
16. SAS Institute Inc., SAS® Language and Procedures: Usage, Version 6, First Edition, SAS Institute Inc., Cary, NC, 638, 1989.
17. SAS Institute Inc., SAS® Language, Reference Version 6, First Edition, SAS Institute Inc., Cary, NC, 1042, 1990.
18. SAS Institute Inc., SAS® Procedures Guide, Version 6, Third Edition, SAS Institute Inc., Cary, NC, 705, 1990.
19. Cody, R.P., and Smith, J.K., Applied Statistics and the SAS® Programming Language, Third Ed., Elsevier Science Publishing Co., Inc., 1991.
20. Dunnett, C.W., A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc., 50:1096, 1955.
21. Dunnett, C.W., New tables for multiple comparisons with a control. Biometrics, 20:482, 1964.
22. Balaguer, P., Joyeux, A., Denison, M., Vincent, R., Gillesby, B., and Zacharewski, T., Assessing the estrogenic and dioxin-like activities of chemicals and complex mixtures using in vitro recombinant receptor/reporter gene assays, Can. J. Physiol. Pharmacol., 74:216, 1996.
23. Connor, K., Howell, J., Chen, I., Liu, H., Berhane, K., Sciarretta, C., Safe, S., and Zacharewski, T., Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro, Fund. Appl. Toxicol., 30:93, 1995.
24. Moore, M., Mustain, M., Daniel, K., Chen, I., Safe, S., Zacharewski, T., Gillesby, B., Joyeux, A., and Balaguer, P., Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum, Toxicol. Appl. Pharmacol., 142:160, 1997.
25. Zacharewski, T., Berhane, K., Gillesby, B., and Burnison, K., Detection of estrogen- and dioxin-like activity in pulp and paper mill black liquor effluent using in vitro recombinant receptor/reporter gene assays, Environ. Sci. Tech., 29:2140, 1995.
26. Sambrook, J., Fristch, E. F., and Maniatis, T., Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York, 1989.
27. Berry, M., Metzger, D., and Chambon, P., Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonist activity of the anti-oestrogen 4-hydroxytamoxifen, EMBO J., 9:2811, 1990.
28. Brasier, A. R., Tate, J. E., and Habener, J. F., Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines, Biotechniques, 7:1116, 1989.
29. Lickly, T.D., Breder, C.V., and Rainey, M.L., A Model for Estimating the Daily Dietary Intake of a Substance from Food-Contact Articles: Styrene from Polystyrene Food-Contact Polymers, Regulatory Toxicology and Pharmacology, 21:406, 1995.
30. The Society of the Plastics Industry, Inc., Food, Drug, and Cosmetics Packaging Materials Committee, Ad Hoc Styrene Migration Task Group, "The Safety of Styrene-Based Polymers for Food-Contact Use," 1993.
31. Food and Drug Administration, Title 21, Code of Federal Regulations, Section 176.170(c), Table 2, 1998.
32. Food and Drug Administration, Title 21, Code of Federal Regulations, Section 176.170(c), Table 1, 1998.